1. Home
  2. ICHR vs MDXG Comparison

ICHR vs MDXG Comparison

Compare ICHR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$48.59

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$4.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
MDXG
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.0B
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
ICHR
MDXG
Price
$48.59
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$45.67
$10.00
AVG Volume (30 Days)
670.7K
780.8K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
0.32
Revenue
$947,652,000.00
$418,630,000.00
Revenue This Year
$18.08
N/A
Revenue Next Year
$12.06
$13.14
P/E Ratio
N/A
$13.03
Revenue Growth
11.61
19.99
52 Week Low
$13.15
$4.12
52 Week High
$55.00
$8.12

Technical Indicators

Market Signals
Indicator
ICHR
MDXG
Relative Strength Index (RSI) 57.67 23.10
Support Level $15.74 N/A
Resistance Level $55.00 $5.38
Average True Range (ATR) 3.53 0.16
MACD -0.05 -0.02
Stochastic Oscillator 73.04 8.86

Price Performance

Historical Comparison
ICHR
MDXG

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: